$HBRM/ excerpt#4 / Herborium Enters the Hispanic M
Post# of 125
(Total Views: 4106)
Posted On: 03/23/2017 5:42:47 PM
$HBRM/ excerpt#4 / Herborium Enters the Hispanic Market with Its Signature Product-AcnEase; Company Reconfirms the Up-Listing Strategy
Fort Lee, NJ -- (ReleaseWire) -- 03/23/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), http://www.Herborium.com, a Botanical Therapeutics® Company
and the provider of unique all botanical medicinal products (Botanical Therapeutics®)
About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals.
The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).
The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry:
Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.
Herborium has secured a pipeline of botanical ingredients based
products in the areas of dermatological needs,
wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants,
diabetes, surgical procedures, and other issues.
Herborium Group sells its products in the United States,
the United Kingdom, and
continental Europe through a network of distributors, specialty retailers,
and e-commerce.
For more information, please visit http://www.herborium.com, http://www.acnease.com,
http://www.acnease.fr.
Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Contact Information:
Herborium Group, Inc.
Email: InvestorRelations@Herborium.com or DrAgnes@Herborium.comFor more information on this press release visit: http://www.releasewire.com/press-releases/her...5.htmMedia Relations ContactDr. Agnes
Email: Click to Email Dr. Agnes
Web: http://www.herborium.com
Fort Lee, NJ -- (ReleaseWire) -- 03/23/2017 -- Herborium® Group, Inc. (OTCMKTS:HBRM), http://www.Herborium.com, a Botanical Therapeutics® Company
and the provider of unique all botanical medicinal products (Botanical Therapeutics®)
About Herborium Group, Inc.
Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals.
The Company's business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).
The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry:
Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.
Herborium has secured a pipeline of botanical ingredients based
products in the areas of dermatological needs,
wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants,
diabetes, surgical procedures, and other issues.
Herborium Group sells its products in the United States,
the United Kingdom, and
continental Europe through a network of distributors, specialty retailers,
and e-commerce.
For more information, please visit http://www.herborium.com, http://www.acnease.com,
http://www.acnease.fr.
Safe Harbor Statement:
This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Contact Information:
Herborium Group, Inc.
Email: InvestorRelations@Herborium.com or DrAgnes@Herborium.comFor more information on this press release visit: http://www.releasewire.com/press-releases/her...5.htmMedia Relations ContactDr. Agnes
Email: Click to Email Dr. Agnes
Web: http://www.herborium.com
(0)
(0)Herborium Group Inc. (HBRM) Stock Research Links
Scroll down for more posts ▼